Publicaciones en colaboración con investigadores/as de Hospital de Mataró (7)

2022

  1. Gadolinium-enhanced brain lesions in multiple sclerosis relapse

    Neurologia, Vol. 37, Núm. 7, pp. 557-563

2021

  1. Direct costs of relapses in patients with relapsing-remitting multiple sclerosis

    Neurology Perspectives, Vol. 1, Núm. 3, pp. 160-169

2019

  1. Th1Th17CM lymphocyte subpopulation as a predictive biomarker of disease activity in multiple sclerosis patients under dimethyl fumarate or fingolimod treatment

    Mediators of Inflammation, Vol. 2019

2018

  1. Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

    Multiple Sclerosis Journal, Vol. 24, Núm. 14, pp. 1843-1851

  2. Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients

    CNS Neuroscience and Therapeutics, Vol. 24, Núm. 12, pp. 1175-1184

2016

  1. Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses

    Multiple Sclerosis, Vol. 22, Núm. 1, pp. 117-121

2014

  1. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS

    Multiple Sclerosis Journal, Vol. 20, Núm. 6, pp. 717-725